Other — Revenue
Products & Services · RevenueEli Lilly Other — Revenue decreased by 43.2% to $191.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from $190.70M to $191.40M. Over 4 years (FY 2021 to FY 2025), Other — Revenue shows a downward trend with a -30.9% CAGR.
Analysis
How to read this metric
An increase suggests successful lifecycle management or unexpected demand for legacy products, while a decrease may indicate portfolio pruning or the natural decline of older, off-patent medications.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products that do not fall into the company's pr...
Peer comparison
Peers typically report this as 'Other' or 'Legacy' product revenue, often representing a declining percentage of total sales as companies shift focus toward high-growth therapeutic areas.
lly_segment_other_product_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $712.90M | $637.70M | $1.54B | $1.92B | $494.70M | $746.00M | $356.00M | $275.30M | $314.60M | $276.10M | $256.20M | $241.90M | $207.60M | $262.80M | $190.70M | $212.90M | $201.50M | $337.20M | $191.40M |
| QoQ Change | — | -10.5% | +140.9% | +25.2% | -74.3% | +50.8% | -52.3% | -22.7% | +14.3% | -12.2% | -7.2% | -5.6% | -14.2% | +26.6% | -27.4% | +11.6% | -5.4% | +67.3% | -43.2% |
| YoY Change | — | — | — | — | -30.6% | +17.0% | -76.8% | -85.7% | -36.4% | -63.0% | -28.0% | -12.1% | -34.0% | -4.8% | -25.6% | -12.0% | -2.9% | +28.3% | +0.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other — revenue?
- Eli Lilly (LLY) reported other — revenue of $191.40M in Q4 2025.
- How has Eli Lilly's other — revenue changed year-over-year?
- Eli Lilly's other — revenue increased by 0.4% year-over-year, from $190.70M to $191.40M.
- What is the long-term trend for Eli Lilly's other — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's other — revenue has grown at a -30.9% compound annual growth rate (CAGR), from $4.13B to $943.00M.
- What does other — revenue mean?
- The total revenue generated from the company's secondary or non-core pharmaceutical product lines.